61/1304/2026 - Drug Panel Reagents
About This Opportunity
TranslatedThis tender, identified as 61/1304/2026, pertains to the procurement of drug panel reagents. The primary objective is to acquire high-quality reagents that are essential for conducting drug testing and analysis. These reagents are crucial for laboratories and healthcare facilities that perform toxicology screenings and drug monitoring. Key requirements for bidders may include the provision of detailed specifications for the reagents, compliance with relevant health and safety standards, and evidence of previous successful contracts in similar fields. Additionally, suppliers should demonstrate their capacity to deliver the reagents within specified timelines and ensure the reliability and accuracy of the products offered. The tender is open to suppliers with expertise in chemical manufacturing and distribution, particularly those who can provide a range of reagents suitable for various drug testing methodologies. Interested parties are encouraged to review the tender documents thoroughly to understand the submission process, evaluation criteria, and any specific conditions that must be met. The location for the delivery of these reagents will be specified in the tender documentation, and it is essential for bidders to consider logistics and distribution capabilities when preparing their proposals. This tender represents an important opportunity for suppliers in the pharmaceutical and laboratory sectors to engage in public procurement.
This is a supplies contract in the health and medical services, transport and logistics and Research sectors, with a focus on Pharmaceuticals, Laboratory, Logistics and Laboratories. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 7,152.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: SpanishThe tender titled 61/1304/2026 pertains to the procurement of drug panel reagents in Portugal. This initiative is part of the broader efforts by public health authorities to enhance drug testing capabilities across various institutions within the country. The contracting authority overseeing this tender is expected to be a public health organization or governmental agency focused on maintaining and improving public safety through effective drug analysis.
The primary objective of this procurement is to acquire high-quality reagents essential for conducting drug tests. These reagents must meet specific standards to ensure accuracy and reliability in testing procedures. Successful bidders will need to demonstrate their ability to supply reagents that comply with applicable regulatory requirements and industry standards.
Typical requirements for this type of tender may include the provision of detailed specifications of the reagents, quality assurance protocols, and evidence of prior experience in supplying similar products. Additionally, bidders may be expected to outline their logistics capabilities, ensuring timely delivery and support services.
This tender represents a significant opportunity for suppliers specializing in laboratory products, particularly those with expertise in drug testing reagents. Companies interested in participating should prepare to present their qualifications and demonstrate their commitment to quality and compliance with public health standards. As this procurement is part of the public sector, transparency and adherence to competitive bidding processes are paramount. Interested parties are encouraged to monitor the BASE portal for further details and submission guidelines.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 20, 2026. Last refreshed 6 days ago. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Algarve, E.P.E
Unidade Local de Saúde do Algarve, E.P.E has issued 659 procurement notices on BidsFactory, including 0 currently open and 613 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €7,152. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Normax - Fábrica de Vidros Científicos, Lda.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Algarve, E.P.E in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.